Psoriatic Arthritis (PsA) Treatment Market Report

China Psoriatic Arthritis (PsA) Treatment Market Professional Research Report 2022-2027, Segmented by Players, Types, End-Users in Major Regions

  • POSTDATE：Aug 21, 2022
  • PAGES：223
  • REPORT CODE：GMM1076229
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report offers an overview of the market trends, drivers, and barriers with respect to the China Psoriatic Arthritis (PsA) Treatment market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Psoriatic Arthritis (PsA) Treatment market. Detailed analysis of key players, along with key growth strategies adopted by Psoriatic Arthritis (PsA) Treatment industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • AstraZeneca plc

    • Novartis International AG

    • Johnson & Johnson Services Inc

    • Bausch Health Companies Inc

    • Amgen Inc

    • AbbVie Inc

    • Celgene Corporation

    By Type:

    • Nonsteriodal Anti-inflammatory Drugs

    • Disease Modifying Antirheumatic Drugs

    • Biologics

    By End-User:

    • Hospitals

    • Clinics

    • Others

    By Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Psoriatic Arthritis (PsA) Treatment Market

    • 1.3 Market Segment by Type

    • 1.3.1 China Psoriatic Arthritis (PsA) Treatment Market Size and Growth Rate of Nonsteriodal Anti-inflammatory Drugs from 2016 to 2027

    • 1.3.2 China Psoriatic Arthritis (PsA) Treatment Market Size and Growth Rate of Disease Modifying Antirheumatic Drugs from 2016 to 2027

    • 1.3.3 China Psoriatic Arthritis (PsA) Treatment Market Size and Growth Rate of Biologics from 2016 to 2027

    • 1.4 Market Segment by Application

    • 1.4.1 China Psoriatic Arthritis (PsA) Treatment Market Size and Growth Rate of Hospitals from 2016 to 2027

    • 1.4.2 China Psoriatic Arthritis (PsA) Treatment Market Size and Growth Rate of Clinics from 2016 to 2027

    • 1.4.3 China Psoriatic Arthritis (PsA) Treatment Market Size and Growth Rate of Others from 2016 to 2027

    • 1.5 Market Segment by Regions

      • 1.5.1 North China Psoriatic Arthritis (PsA) Treatment Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.2 Central China Psoriatic Arthritis (PsA) Treatment Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.3 South China Psoriatic Arthritis (PsA) Treatment Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.4 East China Psoriatic Arthritis (PsA) Treatment Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.5 Northeast China Psoriatic Arthritis (PsA) Treatment Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.6 Southwest China Psoriatic Arthritis (PsA) Treatment Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.7 Northwest China Psoriatic Arthritis (PsA) Treatment Consumption Market Size and Growth Rate from 2016 to 2027

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    • 2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry

    3 Segmentation of Psoriatic Arthritis (PsA) Treatment Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Psoriatic Arthritis (PsA) Treatment by Major Types

    • 3.4.1 Market Size and Growth Rate of Nonsteriodal Anti-inflammatory Drugs

    • 3.4.2 Market Size and Growth Rate of Disease Modifying Antirheumatic Drugs

    • 3.4.3 Market Size and Growth Rate of Biologics

    4 Segmentation of Psoriatic Arthritis (PsA) Treatment Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Psoriatic Arthritis (PsA) Treatment by Major End-Users

    • 4.4.1 Market Size and Growth Rate of Psoriatic Arthritis (PsA) Treatment in Hospitals

    • 4.4.2 Market Size and Growth Rate of Psoriatic Arthritis (PsA) Treatment in Clinics

    • 4.4.3 Market Size and Growth Rate of Psoriatic Arthritis (PsA) Treatment in Others

    5 Market Analysis by Regions

    • 5.1 China Psoriatic Arthritis (PsA) Treatment Production Analysis by Regions

    • 5.2 China Psoriatic Arthritis (PsA) Treatment Consumption Analysis by Regions

    • 5.3 Coronavirus (COVID-19) Impact on China Economy

    6 North China Psoriatic Arthritis (PsA) Treatment Landscape Analysis

    • 6.1 North China Psoriatic Arthritis (PsA) Treatment Landscape Analysis by Major Types

    • 6.2 North China Psoriatic Arthritis (PsA) Treatment Landscape Analysis by Major End-Users

    7 Central China Psoriatic Arthritis (PsA) Treatment Landscape Analysis

    • 7.1 Central China Psoriatic Arthritis (PsA) Treatment Landscape Analysis by Major Types

    • 7.2 Central China Psoriatic Arthritis (PsA) Treatment Landscape Analysis by Major End-Users

    8 South China Psoriatic Arthritis (PsA) Treatment Landscape Analysis

    • 8.1 South China Psoriatic Arthritis (PsA) Treatment Landscape Analysis by Major Types

    • 8.2 South China Psoriatic Arthritis (PsA) Treatment Landscape Analysis by Major End-Users

    9 East China Psoriatic Arthritis (PsA) Treatment Landscape Analysis

    • 9.1 East China Psoriatic Arthritis (PsA) Treatment Landscape Analysis by Major Types

    • 9.2 East China Psoriatic Arthritis (PsA) Treatment Landscape Analysis by Major End-Users

    10 Northeast China Psoriatic Arthritis (PsA) Treatment Landscape Analysis

    • 10.1 Northeast China Psoriatic Arthritis (PsA) Treatment Landscape Analysis by Major Types

    • 10.2 Northeast China Psoriatic Arthritis (PsA) Treatment Landscape Analysis by Major End-Users

    11 Southwest China Psoriatic Arthritis (PsA) Treatment Landscape Analysis

    • 11.1 Southwest China Psoriatic Arthritis (PsA) Treatment Landscape Analysis by Major Types

    • 11.2 Southwest China Psoriatic Arthritis (PsA) Treatment Landscape Analysis by Major End-Users

    12 Northwest China Psoriatic Arthritis (PsA) Treatment Landscape Analysis

    • 12.1 Northwest China Psoriatic Arthritis (PsA) Treatment Landscape Analysis by Major Types

    • 12.2 Northwest China Psoriatic Arthritis (PsA) Treatment Landscape Analysis by Major End-Users

    13 Major Players Profiles

    • 13.1 AstraZeneca plc

      • 13.1.1 AstraZeneca plc Company Profile and Recent Development

      • 13.1.2 Market Performance

      • 13.1.3 Product and Service Introduction

    • 13.2 Novartis International AG

      • 13.2.1 Novartis International AG Company Profile and Recent Development

      • 13.2.2 Market Performance

      • 13.2.3 Product and Service Introduction

    • 13.3 Johnson & Johnson Services Inc

      • 13.3.1 Johnson & Johnson Services Inc Company Profile and Recent Development

      • 13.3.2 Market Performance

      • 13.3.3 Product and Service Introduction

    • 13.4 Bausch Health Companies Inc

      • 13.4.1 Bausch Health Companies Inc Company Profile and Recent Development

      • 13.4.2 Market Performance

      • 13.4.3 Product and Service Introduction

    • 13.5 Amgen Inc

      • 13.5.1 Amgen Inc Company Profile and Recent Development

      • 13.5.2 Market Performance

      • 13.5.3 Product and Service Introduction

    • 13.6 AbbVie Inc

      • 13.6.1 AbbVie Inc Company Profile and Recent Development

      • 13.6.2 Market Performance

      • 13.6.3 Product and Service Introduction

    • 13.7 Celgene Corporation

      • 13.7.1 Celgene Corporation Company Profile and Recent Development

      • 13.7.2 Market Performance

      • 13.7.3 Product and Service Introduction

    The List of Tables and Figures

    • Figure Product Picture

    • Figure China Psoriatic Arthritis (PsA) Treatment Market Size and Growth Rate of Nonsteriodal Anti-inflammatory Drugs from 2016 to 2027

    • Figure China Psoriatic Arthritis (PsA) Treatment Market Size and Growth Rate of Disease Modifying Antirheumatic Drugs from 2016 to 2027

    • Figure China Psoriatic Arthritis (PsA) Treatment Market Size and Growth Rate of Biologics from 2016 to 2027

    • Figure Market Share by Type in 2016

    • Figure Market Share by Type in 2021

    • Figure Market Share by Type in 2027

    • Figure China Psoriatic Arthritis (PsA) Treatment Market Size and Growth Rate of Hospitals from 2016 to 2027

    • Figure China Psoriatic Arthritis (PsA) Treatment Market Size and Growth Rate of Clinics from 2016 to 2027

    • Figure China Psoriatic Arthritis (PsA) Treatment Market Size and Growth Rate of Others from 2016 to 2027

    • Figure Market Share by End-User in 2016

    • Figure Market Share by End-User in 2021

    • Figure Market Share by End-User in 2027

    • Figure North China Psoriatic Arthritis (PsA) Treatment Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Central China Psoriatic Arthritis (PsA) Treatment Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure South China Psoriatic Arthritis (PsA) Treatment Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure East China Psoriatic Arthritis (PsA) Treatment Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northeast China Psoriatic Arthritis (PsA) Treatment Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Southwest China Psoriatic Arthritis (PsA) Treatment Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northwest China Psoriatic Arthritis (PsA) Treatment Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Development Trends and Industry Dynamics of Psoriatic Arthritis (PsA) Treatment Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2020

    • Figure Market Share of TOP 5 Players in 2021

    • Figure Market Share of TOP 6 Players from 2016 to 2021

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Figure Coronavirus (COVID-19) Map of China

    • Table Coronavirus (COVID-19) Impact on the Industry

    • Figure Specifications of Different Types of Psoriatic Arthritis (PsA) Treatment

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Psoriatic Arthritis (PsA) Treatment by Different Types from 2016 to 2027

    • Table Consumption Share of Psoriatic Arthritis (PsA) Treatment by Different Types from 2016 to 2027

    • Figure Market Size and Growth Rate of Nonsteriodal Anti-inflammatory Drugs

    • Figure Market Size and Growth Rate of Disease Modifying Antirheumatic Drugs

    • Figure Market Size and Growth Rate of Biologics

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Figure Consumption of Psoriatic Arthritis (PsA) Treatment by Different End-Users from 2016 to 2027

    • Table Consumption Share of Psoriatic Arthritis (PsA) Treatment by Different End-Users from 2016 to 2027

    • Figure Market Size and Growth Rate of Hospitals

    • Figure Market Size and Growth Rate of Clinics

    • Figure Market Size and Growth Rate of Others

    • Table China Psoriatic Arthritis (PsA) Treatment Production by Regions

    • Table China Psoriatic Arthritis (PsA) Treatment Production Share by Regions

    • Figure China Psoriatic Arthritis (PsA) Treatment Production Share by Regions in 2016

    • Figure China Psoriatic Arthritis (PsA) Treatment Production Share by Regions in 2021

    • Figure China Psoriatic Arthritis (PsA) Treatment Production Share by Regions in 2027

    • Table China Psoriatic Arthritis (PsA) Treatment Consumption by Regions

    • Table China Psoriatic Arthritis (PsA) Treatment Consumption Share by Regions

    • Figure China Psoriatic Arthritis (PsA) Treatment Consumption Share by Regions in 2016

    • Figure China Psoriatic Arthritis (PsA) Treatment Consumption Share by Regions in 2021

    • Figure China Psoriatic Arthritis (PsA) Treatment Consumption Share by Regions in 2027

    • Table North China Psoriatic Arthritis (PsA) Treatment Consumption by Types from 2016 to 2027

    • Table North China Psoriatic Arthritis (PsA) Treatment Consumption Share by Types from 2016 to 2027

    • Figure North China Psoriatic Arthritis (PsA) Treatment Consumption Share by Types in 2016

    • Figure North China Psoriatic Arthritis (PsA) Treatment Consumption Share by Types in 2021

    • Figure North China Psoriatic Arthritis (PsA) Treatment Consumption Share by Types in 2027

    • Table North China Psoriatic Arthritis (PsA) Treatment Consumption by End-Users from 2016 to 2027

    • Table North China Psoriatic Arthritis (PsA) Treatment Consumption Share by End-Users from 2016 to 2027

    • Figure North China Psoriatic Arthritis (PsA) Treatment Consumption Share by End-Users in 2016

    • Figure North China Psoriatic Arthritis (PsA) Treatment Consumption Share by End-Users in 2021

    • Figure North China Psoriatic Arthritis (PsA) Treatment Consumption Share by End-Users in 2027

    • Table Central China Psoriatic Arthritis (PsA) Treatment Consumption by Types from 2016 to 2027

    • Table Central China Psoriatic Arthritis (PsA) Treatment Consumption Share by Types from 2016 to 2027

    • Figure Central China Psoriatic Arthritis (PsA) Treatment Consumption Share by Types in 2016

    • Figure Central China Psoriatic Arthritis (PsA) Treatment Consumption Share by Types in 2021

    • Figure Central China Psoriatic Arthritis (PsA) Treatment Consumption Share by Types in 2027

    • Table Central China Psoriatic Arthritis (PsA) Treatment Consumption by End-Users from 2016 to 2027

    • Table Central China Psoriatic Arthritis (PsA) Treatment Consumption Share by End-Users from 2016 to 2027

    • Figure Central China Psoriatic Arthritis (PsA) Treatment Consumption Share by End-Users in 2016

    • Figure Central China Psoriatic Arthritis (PsA) Treatment Consumption Share by End-Users in 2021

    • Figure Central China Psoriatic Arthritis (PsA) Treatment Consumption Share by End-Users in 2027

    • Table South China Psoriatic Arthritis (PsA) Treatment Consumption by Types from 2016 to 2027

    • Table South China Psoriatic Arthritis (PsA) Treatment Consumption Share by Types from 2016 to 2027

    • Figure South China Psoriatic Arthritis (PsA) Treatment Consumption Share by Types in 2016

    • Figure South China Psoriatic Arthritis (PsA) Treatment Consumption Share by Types in 2021

    • Figure South China Psoriatic Arthritis (PsA) Treatment Consumption Share by Types in 2027

    • Table South China Psoriatic Arthritis (PsA) Treatment Consumption by End-Users from 2016 to 2027

    • Table South China Psoriatic Arthritis (PsA) Treatment Consumption Share by End-Users from 2016 to 2027

    • Figure South China Psoriatic Arthritis (PsA) Treatment Consumption Share by End-Users in 2016

    • Figure South China Psoriatic Arthritis (PsA) Treatment Consumption Share by End-Users in 2021

    • Figure South China Psoriatic Arthritis (PsA) Treatment Consumption Share by End-Users in 2027

    • Table East China Psoriatic Arthritis (PsA) Treatment Consumption by Types from 2016 to 2027

    • Table East China Psoriatic Arthritis (PsA) Treatment Consumption Share by Types from 2016 to 2027

    • Figure East China Psoriatic Arthritis (PsA) Treatment Consumption Share by Types in 2016

    • Figure East China Psoriatic Arthritis (PsA) Treatment Consumption Share by Types in 2021

    • Figure East China Psoriatic Arthritis (PsA) Treatment Consumption Share by Types in 2027

    • Table East China Psoriatic Arthritis (PsA) Treatment Consumption by End-Users from 2016 to 2027

    • Table East China Psoriatic Arthritis (PsA) Treatment Consumption Share by End-Users from 2016 to 2027

    • Figure East China Psoriatic Arthritis (PsA) Treatment Consumption Share by End-Users in 2016

    • Figure East China Psoriatic Arthritis (PsA) Treatment Consumption Share by End-Users in 2021

    • Figure East China Psoriatic Arthritis (PsA) Treatment Consumption Share by End-Users in 2027

    • Table Northeast China Psoriatic Arthritis (PsA) Treatment Consumption by Types from 2016 to 2027

    • Table Northeast China Psoriatic Arthritis (PsA) Treatment Consumption Share by Types from 2016 to 2027

    • Figure Northeast China Psoriatic Arthritis (PsA) Treatment Consumption Share by Types in 2016

    • Figure Northeast China Psoriatic Arthritis (PsA) Treatment Consumption Share by Types in 2021

    • Figure Northeast China Psoriatic Arthritis (PsA) Treatment Consumption Share by Types in 2027

    • Table Northeast China Psoriatic Arthritis (PsA) Treatment Consumption by End-Users from 2016 to 2027

    • Table Northeast China Psoriatic Arthritis (PsA) Treatment Consumption Share by End-Users from 2016 to 2027

    • Figure Northeast China Psoriatic Arthritis (PsA) Treatment Consumption Share by End-Users in 2016

    • Figure Northeast China Psoriatic Arthritis (PsA) Treatment Consumption Share by End-Users in 2021

    • Figure Northeast China Psoriatic Arthritis (PsA) Treatment Consumption Share by End-Users in 2027

    • Table Southwest China Psoriatic Arthritis (PsA) Treatment Consumption by Types from 2016 to 2027

    • Table Southwest China Psoriatic Arthritis (PsA) Treatment Consumption Share by Types from 2016 to 2027

    • Figure Southwest China Psoriatic Arthritis (PsA) Treatment Consumption Share by Types in 2016

    • Figure Southwest China Psoriatic Arthritis (PsA) Treatment Consumption Share by Types in 2021

    • Figure Southwest China Psoriatic Arthritis (PsA) Treatment Consumption Share by Types in 2027

    • Table Southwest China Psoriatic Arthritis (PsA) Treatment Consumption by End-Users from 2016 to 2027

    • Table Southwest China Psoriatic Arthritis (PsA) Treatment Consumption Share by End-Users from 2016 to 2027

    • Figure Southwest China Psoriatic Arthritis (PsA) Treatment Consumption Share by End-Users in 2016

    • Figure Southwest China Psoriatic Arthritis (PsA) Treatment Consumption Share by End-Users in 2021

    • Figure Southwest China Psoriatic Arthritis (PsA) Treatment Consumption Share by End-Users in 2027

    • Table Northwest China Psoriatic Arthritis (PsA) Treatment Consumption by Types from 2016 to 2027

    • Table Northwest China Psoriatic Arthritis (PsA) Treatment Consumption Share by Types from 2016 to 2027

    • Figure Northwest China Psoriatic Arthritis (PsA) Treatment Consumption Share by Types in 2016

    • Figure Northwest China Psoriatic Arthritis (PsA) Treatment Consumption Share by Types in 2021

    • Figure Northwest China Psoriatic Arthritis (PsA) Treatment Consumption Share by Types in 2027

    • Table Northwest China Psoriatic Arthritis (PsA) Treatment Consumption by End-Users from 2016 to 2027

    • Table Northwest China Psoriatic Arthritis (PsA) Treatment Consumption Share by End-Users from 2016 to 2027

    • Figure Northwest China Psoriatic Arthritis (PsA) Treatment Consumption Share by End-Users in 2016

    • Figure Northwest China Psoriatic Arthritis (PsA) Treatment Consumption Share by End-Users in 2021

    • Figure Northwest China Psoriatic Arthritis (PsA) Treatment Consumption Share by End-Users in 2027

    • Table Company Profile and Development Status of AstraZeneca plc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of AstraZeneca plc

    • Figure Sales and Growth Rate Analysis of AstraZeneca plc

    • Figure Revenue and Market Share Analysis of AstraZeneca plc

    • Table Product and Service Introduction of AstraZeneca plc

    • Table Company Profile and Development Status of Novartis International AG

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis International AG

    • Figure Sales and Growth Rate Analysis of Novartis International AG

    • Figure Revenue and Market Share Analysis of Novartis International AG

    • Table Product and Service Introduction of Novartis International AG

    • Table Company Profile and Development Status of Johnson & Johnson Services Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Johnson & Johnson Services Inc

    • Figure Sales and Growth Rate Analysis of Johnson & Johnson Services Inc

    • Figure Revenue and Market Share Analysis of Johnson & Johnson Services Inc

    • Table Product and Service Introduction of Johnson & Johnson Services Inc

    • Table Company Profile and Development Status of Bausch Health Companies Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bausch Health Companies Inc

    • Figure Sales and Growth Rate Analysis of Bausch Health Companies Inc

    • Figure Revenue and Market Share Analysis of Bausch Health Companies Inc

    • Table Product and Service Introduction of Bausch Health Companies Inc

    • Table Company Profile and Development Status of Amgen Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Amgen Inc

    • Figure Sales and Growth Rate Analysis of Amgen Inc

    • Figure Revenue and Market Share Analysis of Amgen Inc

    • Table Product and Service Introduction of Amgen Inc

    • Table Company Profile and Development Status of AbbVie Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of AbbVie Inc

    • Figure Sales and Growth Rate Analysis of AbbVie Inc

    • Figure Revenue and Market Share Analysis of AbbVie Inc

    • Table Product and Service Introduction of AbbVie Inc

    • Table Company Profile and Development Status of Celgene Corporation

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Celgene Corporation

    • Figure Sales and Growth Rate Analysis of Celgene Corporation

    • Figure Revenue and Market Share Analysis of Celgene Corporation

    • Table Product and Service Introduction of Celgene Corporation


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US